Gut Microbiome–Colorectal Cancer Relationship

Devvrat Yadav,Chiranjeevi Sainatham,Evgenii Filippov,Sai Gautham Kanagala,Syed Murtaza Ishaq,Thejus Jayakrishnan

DOI: https://doi.org/10.3390/microorganisms12030484

IF: 4.5

2024-02-27

Microorganisms

Abstract:Traditionally, the role of gut dysbiosis was thought to be limited to pathologies like Clostridioides difficile infection, but studies have shown its role in other intestinal and extraintestinal pathologies. Similarly, recent studies have surfaced showing the strong potential role of the gut microbiome in colorectal cancer, which was traditionally attributed mainly to sporadic or germline mutations. Given that it is the third most common cancer and the second most common cause of cancer-related mortality, 78 grants totaling more than USD 28 million have been granted to improve colon cancer management since 2019. Concerted efforts by several of these studies have identified specific bacterial consortia inducing a proinflammatory environment and promoting genotoxin production, causing the induction or progression of colorectal cancer. In addition, changes in the gut microbiome have also been shown to alter the response to cancer chemotherapy and immunotherapy, thus changing cancer prognosis. Certain bacteria have been identified as biomarkers to predict the efficacy of antineoplastic medications. Given these discoveries, efforts have been made to alter the gut microbiome to promote a favorable diversity to improve cancer progression and the response to therapy. In this review, we expand on the gut microbiome, its association with colorectal cancer, and antineoplastic medications. We also discuss the evolving paradigm of fecal microbiota transplantation in the context of colorectal cancer management.

microbiology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the relationship between the gut microbiome and colorectal cancer. Specifically, the research focuses on the following aspects:

1. **The role of the gut microbiome in colorectal cancer**: The paper discusses the potential mechanisms of the gut microbiome in the occurrence and development of colorectal cancer. This includes how specific bacterial communities induce a pro - inflammatory environment and promote the production of genotoxins, thereby leading to the occurrence or progression of colorectal cancer.

2. **The impact of the gut microbiome on chemotherapy and immunotherapy**: The research also explores how changes in the gut microbiome affect the response of colorectal cancer patients to chemotherapy and immunotherapy, and thus change the prognosis of cancer. Certain bacteria have been identified as biomarkers that can predict the efficacy of anti - tumor drugs.

3. **The application of fecal microbiota transplantation in colorectal cancer management**: The paper discusses the possibility of changing the gut microbiome through fecal microbiota transplantation (FMT) to promote favorable diversity and improve cancer progression and response to treatment.

4. **The gut microbiome and the prevention and early detection of colorectal cancer**: The research also involves how to use the characteristics of the gut microbiome for the early detection and prevention of colorectal cancer.

In summary, this review paper aims to comprehensively analyze the complex relationship between the gut microbiome and colorectal cancer and explore potential strategies for improving colorectal cancer management and treatment by modulating the gut microbiome.